TP53 and neoplasm: Taken together, sirt6 depletion enhanced the onset and diversified the type of tumors in the Trp53+/- background, given that Sirt6 is a tumor suppressor itself (Lerrer and Cohen, 2013; Sebastián et al., 2012 ).